About POINT Biomedical
POINT Biomedical was a Healthcare company based in San Carlos (United States) founded in 1996. It offers a product for cardiologists to conduct myocardial perfusion imaging studies. It operates on a B2B model. POINT Biomedical has raised $56.4 million across 3 funding rounds from investors including Credit Suisse, Frazier Healthcare Partners and De Novo Ventures. The company is recorded as dissolved. Its focus areas include Healthcare and Life Sciences, Medical Devices, Diagnostic Imaging and Cardiovascular Tools. Its competitors include Biological Dynamics, Nanosphere and Infraredx; 3 of its 3 listed competitors have raised funding.
Company details
POINT Biomedical, established in 1996 and currently in Dissolved stage, focuses on healthcare and life sciences, developing medical devices, diagnostic imaging, and cardiovascular tools. Offers a product for cardiologists to conduct myocardial perfusion imaging studies. Adapting to market demands with innovation and client-focused strategies.
- Headquarters San Carlos, United States
- SectorsHealthcare
- Website pointbio.com
- Total Equity Funding$56.4M (USD)
in 3 rounds
- Latest Funding Round$25M (USD), Series E
Jan 2008
- InvestorsCredit Suisse
& 11 more
Funding Insights of POINT Biomedical
POINT Biomedical has successfully raised a total of $56.4M across 3 strategic funding rounds. The most recent funding activity was a Series E round of $25 million completed in January 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $56.4M
- Total Rounds 3
- Last Round Series E — $25M
- First Round $27.1M
(Aug 2004)
- Investors Count 12
All 3 funding rounds of POINT Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2008 | $25M | Series E | – | – | |
| Jul 2007 | $4.3M | Private Equity Round | – | – | – |
| Aug 2004 | $27.1M | Private Equity Round | – | – |
12 investors in total: 12 institutional.
Investors in POINT Biomedical
POINT Biomedical has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Frazier Healthcare Partners and De Novo Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| denovovc.com | ||||
A biotechnology venture capital firm investing in innovative science. | srone.com | |||
Early stage healthcare services investments are facilitated by CHL. | chlmedical.com | Westport, United States | ||
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States | |
Gruppo Fininvest is engaged in media, finance, and sports sectors. | 1975 | fininvest.it | Milano, Italy | |
Growth in technology companies is supported through venture capital. | ivp.com | Menlo Park, United States | ||
Growth & late stage life sciences and tech focused venture capital firm funding companies in the US | mosaixventures.com | Chicago, United States | ||
Healthcare sector investments are managed through private equity strategies. | pa-investors.com | Palo Alto, United States | ||
Growth stage VC fund investing in the US, Europe and Canada | oakwoodmedical.com | St. Louis, United States | ||
Diversified asset management services are offered globally by Invesco. | invesco.com | Atlanta, United States |
Investor details for POINT Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of POINT Biomedical
3 dated milestones of POINT Biomedical across 12 years, from founding to its latest funding, stage changes and deals.
- Founded POINT Biomedical is founded.
- Funding First funding round of $27.1M.
- Funding Latest funding round, Series E, of $25.0M.
Competitors of POINT Biomedical
POINT Biomedical has 3 listed competitors in our database, 3 of them funded. They include Biological Dynamics, Nanosphere and Infraredx.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biologicaldynamics.com | 2010 | San Diego, United States | $67.65M | 54 | Proprietary lab-on-chip platform for nanoparticle isolation is offered. | |
| nanosphere.us | 1999 | Northbrook, United States | $97.75M | 146 | Diagnostic tests for personalized medicine targeting infections are provided. | |
| infraredx.com | 1998 | Burlington, United States | $99.99M | 59 | Coronary imaging and plaque detection system |
Detailed competitors of POINT Biomedical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as POINT Biomedical (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about POINT Biomedical
POINT Biomedical was founded in 1996 and raised its 1st funding round 8 years after it was founded.
POINT Biomedical is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
POINT Biomedical is a funded company, having raised a total of $56.4M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $27.1M, raised on Aug 2004.
POINT Biomedical, established in 1996 and currently in Dissolved stage, focuses on healthcare and life sciences, developing medical devices, diagnostic imaging, and cardiovascular tools. Offers a product for cardiologists to conduct myocardial perfusion imaging studies. Adapting to market demands with innovation and client-focused strategies.
POINT Biomedical's top competitors include Biological Dynamics, Nanosphere and Infraredx.
POINT Biomedical has 12 investors. Key investors include Credit Suisse, Frazier Healthcare Partners, De Novo Ventures, Invesco, and SR One.